In this study, we focused on the protective effects of endothelium-specific BRG1 deletion in AAA, and our results demonstrated that BRG1 deletion in endothelial cells significantly inhibited Ang II-induced AAA development. This evidence concerns the gene SMARCA4 and triple-A syndrome.